Metabolome Analysis in Patients With Rheumatoid Arthritis
NCT ID: NCT02960958
Last Updated: 2018-01-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
200 participants
OBSERVATIONAL
2016-11-20
2019-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Detection of Pathological Lymphocytes in Patients With Autoimmune Disease
NCT02813083
Gut Microbiota: a Player in Chronic Pain in Patients With Rheumatoid Arthritis?
NCT05822856
Chronic Pain in Rheumatoid Arthritis
NCT05038553
Study of Some Risk Factors for Developing RA
NCT03624179
Clinically Important Changes in Rheumatoid Arthritis
NCT00056602
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
1. Collection urine sample
2. Assessing urine metabolites by 1H NMR spectroscopy
3. Analyzing the relationships between metabolites and clinical variables
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Confirmed with amyloidosis
* Chronic kidney disease (estimated GFR \< 60 ml/min/1.73m2)
* Chronic liver disease
* Thyroid disease
* Pregnancy
* Solid tumor/hematologic malignancy within 5 years
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
The Catholic University of Korea
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jung Hee Koh
MD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jung Hee Koh, MD
Role: PRINCIPAL_INVESTIGATOR
Seoul St.Mary's hospital, The Catholic university of Korea
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CiRAD1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.